雖然這篇fidelio-dkd ppt鄉民發文沒有被收入到精華區:在fidelio-dkd ppt這個話題中,我們另外找到其它相關的精選爆讚文章
[爆卦]fidelio-dkd ppt是什麼?優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#1Finerenone in Reducing Kidney Failure and Disease ...
The FIDELIO-DKD trial showed that finerenone has salutary effects on CV and renal outcomes among patients with T2DM and CKD, who were on a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#2FIDELIO-DKD Trial - SlideShare
Alejandro Recio Mayoral FIDELIO-DKD trial. Heart Failure 2021 Gerasimos Filippatos´s presentation. HF 2021 Finerenone in patients with chronic kidney ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#3Finerenone and Cardiovascular Outcomes in Patients With ...
Background: The FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) evaluated the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#4Presentation title goes here - Clinical Trial Results
FIDELIO -DKD2. Primary outcome: Kidney composite. Finerenone significantly slowed CKD progression by 18% vs placebo in patients with advanced ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#5Efficacy and Safety of Finerenone in Subjects With Type 2 ...
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6Design and Baseline Characteristics of the Finerenone in ...
Methods: The Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD) trial aims to assess the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#7New analyses of the comprehensive finerenone clinical trial ...
13 FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in Diabetic Kidney Disease) investigated the efficacy and safety ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#8FIDELIO-DKD: Finerenone offers new treatment option for ...
FIDELIO -DKD: The mineralocorticoid receptor antagonist finerenone reduces the risk for progression of chronic kidney disease in people with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#9Finerenone Reduces New-Onset Atrial Fibrillation in Patients ...
In the FIDELIO-DKD (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) trial, finerenone significantly ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#10Finerenone in Predominantly Advanced CKD and Type 2 ...
FIDELIO -DKD (FInerenone in reducing kiDnEy faiLure and dIsease prOgression in Diabetic Kidney Disease) investigated the nonsteroidal, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#11Finerenone Reduces CV Outcomes in Patients With Early ...
2021年8月28日 — The study, when coupled with FIDELIO-DKD, now opens up finerenone to ... presentation at the European Society of Cardiology Congress 2021.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#12Finerenone in Diabetic Nephropathy - NephJC
finerenone; fidelio; randomized controlled trial; RCT; NEJM; diabetes; ... The FIDELIO-DKD trial represents another attempt at this ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#13Kidney disease & CVD - PACE-CME
The findings from the FIGARO-DKD trial and the FIDELITY analysis with finerenone in T2DM patients across a broad spectrum of ... This presentation by prof.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#14Finerenone benefits patients with diabetes across spectrum of ...
2021年8月28日 — The FIDELIO-DKD trial previously reported that the drug slowed ... This press release accompanies both a presentation and an ESC press ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#15Bayer's FIDELIO-DKD Phase III Study Demonstrated ...
Bayer's FIDELIO-DKD Phase III Study Demonstrated Investigational Drug Finerenone Significantly Reduced Renal and Cardiovascular Outcomes in ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#16the role of finerenone | Nephrology Dialysis Transplantation
The FIDELIO-DKD (FInerenone in reducing kiDnEy faiLure and dIsease ... CV hospitalization or emergency presentation for worsening heart ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#17Amplification of the presentation of the main results of the ...
FIGARO-DKD included more patients with earlier stage CKD and type 2 diabetes compared with FIDELIO-DKD. The study showed finerenone ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#18Finerenone Cuts Kidney, Heart Risks in CKD and T2D
In FIDELIO-DKD, we hypothesized that the MR antagonism with finerenone would slow kidney disease progression and reduce cardiovascular ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#19An Overview of the FIGARO-DKD Trial Design - American ...
An overview of the FIGARO-DKD trial, which evaluated cardiovascular and renal outcomes in patients with type 2 diabetes and CKD treated with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#20finerenone (Kerendia™) - EOCCO.com
months, with the typical presentation generally considered to include a long ... The FIDELIO-DKD participants consisted of adults (mean age 65) with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#21Finerenone: Fiddling With Hyperkalemia? - American Journal ...
Table 1Details About Hyperkalemia in the FIDELIO Trial ... the embarrassment of riches suddenly at our disposal for treatment of DKD.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#22MRAs in diabetic kidney disease - UKidney
Check out our FIDELIO-DKD Trial Resource · Welcome · Presentations · YouTubule; Resources. ADPKD Channel. ADPKD Channel Home · Ask the Experts: ADPKD ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#23Finerenone - an overview | ScienceDirect Topics
The FIDELIO study has a primary cardiac endpoint with a secondary kidney endpoint, ... are evaluating the safety and efficacy of finerenone in DKD patients, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#24Canagliflozin and Renal Outcomes in Type 2 Diabetes and ...
Abstract Background Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#25Finerenone - Wikipedia
Finerenone, sold under the brand name Kerendia, is a medication used to reduce the risk of ... finerenone is being studied in the large Phase III FIDELIO and FIGARO ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#26Mineralocorticoid Receptor Antagonists in Diabetic Kidney ...
hospitalization or emergency presentation for worsening heart failure ... outcome, an upgraded study, FIDELIO-DKD (FInerenone in reducing ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#27May 14, 2021 This Week in Cardiology Podcast - Medscape
My friends, pay close attention to this presentation at ACC. ... In 2020, in the large FIDELIO-DKD trial, published in the New England ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#28Rajiv Agarwal MD, MS on Twitter: "FIDELIO-DKD talk at ASN ...
FIDELIO -DKD talk at ASN posted here https://youtube.com/watch?v=r8eJ4_rhu9Q… Here are the slides as PPT ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#29Kidney Week 2020 Reimagined: High-Impact Clinical Trials ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#30Finerenone Slows CKD Progression in Diabetic Kidney Disease
In the FIDELIO-DKD (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) ... Oral presentation FR-OR51.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#31FIDELITY: Finerenone Slows CKD Progression Across Full ...
... during his presentation at ASN Kidney Week 2021. With the FIGARO-DKD and FIDELIO-DKD inclusion criteria designed with the aim of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#32CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES
the SGLT2 inhibitor canagliflozin and the FIDELIO-DKD. (Finerenone in Reducing Kidney ... patients with type 2 diabetes because of its variable presentation.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#33Cardiovascular Events with Finerenone in Kidney Disease ...
FIGARO-DKD Investigators: George L Bakris, Gerasimos Filippatos, Rajiv Agarwal, Stefan D Anker, Luis M Ruilope, Bertram Pitt, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#34Reduction of cardiovascular risk in chronic kidney disease by ...
Concurrently FIDELIO-DKD will investigate finerenone in comparison with placebo in 4800 patients with the clinical diagnosis of diabetic ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#35SGLT2-inhibition: - Nefrovisie
MCA (spironolactone). (PRIORITY; ongoing; renal outcome). • MCA (fineronone). (FIGARO and FIDELIO-DKD; ongoing; renal/CV outcome) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#36Kidney Outcomes With Glucagon-Like Peptide-1 Receptor ...
The management of diabetic kidney disease (DKD) has dramatically evolved in ... FIDELIO-DKD: onset of kidney failure, a sustained decrease of eGFR ≥ 40% ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#37Prevalence of Chronic Kidney Disease in Type 2 Diabetes
The Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD) trial found that finerenone ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#38Nierbeschermende behandeling bij chronische nierschade
FIDELIO, FIGARO. • Finerenone en “the potassium issue”. • Klinische trial in DKD met de ERA atrasentan: SONAR. • Atrasentan en “the sodium issue”.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#39Novel therapies for diabetic kidney disease
... finerenone, in the FIDELIO (Efficacy and Safety of Finerenone in Subjects ... 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD) and Efficacy ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#40บริบาลเภสัชกรรม พระนครศรีอยุธยา - Posts | Facebook
ในปึที่แล้วผลการศึกษา FIDELIO-DKD พบว่า Finerenone… More ช่วยชลอการเสื่อมของไต เมื่อเทียบกับยาหลอก. Effect of Finerenone on Chronic Kidney Disease Outcomes ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#41Ch29-Chronic-Kidney-Disease-in-Diabetes.pdf
betic Kidney Disease (FIDELIO-DKD) (ClinicalTrials.gov Identifier. NCT02540993) and Efficacy and Safety of ... of presentation of diabetes mellitus.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#42Mineralocorticoid receptor antagonists: 60 years of research ...
... and the clinical diagnosis of diabetic kidney disease (FIDELIO-DKD) ... data were presented recently in an investor presentation published on Daiichi ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#43Contemporary Management of Heart Failure in Patients With ...
... and emergency presentation for worsening heart failure showed a ... Indeed, the top-line result for FIDELIO-DKD has indicated that the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#44nefropatía diabética - Sociedad de Medicina Interna de ...
FIDELIO -DKD Objetivo primario: Tiempo a la ocurrencia de evento compuesto renal: Inicio de fallo renal, deterioro funcional renal > 40% del basal o muerte ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#45Podocytopathies | Request PDF - ResearchGate
... of focusing not only on the podocytes themselves, but also on the interactions between podocytes and other cells in DKD development.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#46ACC 2021 - Synthèse des études | Cardiologie Pratique
L'essai FIDELIO-DKD publié fin 2020 (1) avait démontré un bénéfice de cette molécule dans la progression de la... Études. 15 oct 2021 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#47Kidney News - August 2020 - American Society of Nephrology
FIDELIO -DKD study of the drug finerenone met its ... Patients often go undiagnosed, as the clinical presentation of AS is highly variable.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#48Industry Symposium Booklet - European Renal Association
GLP-1RA IN DKD: A NEW PREVENTIVE. CHALLENGE ... Although the hum of an in-person debate and presentation will be ... The FIDELIO-DKD trial:.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#49慢性肾病治疗新突破!FIDELIO-DKD研究重磅发布 - Weibo
FIDELIO -DKD研究重磅发布:新型药物显著改善CKD. ... 抑制剂pirtobrutinib和MK-1026在恶性血液肿瘤中的疗效数据(给公众号回复“ASH”下载研究PPT)。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#50High Altitude Renal Syndrome (HARS) - Journal of the ...
The frequent presentation of systemic hypertension and microalbuminuria with relatively preserved GFR coupled with the presence of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#51CARDIOLOGIA - Pharmastar
zione posta alla protezione renale (FIGARO-DKD, FIDELITY- ... dio FIDELIO-DKD, condotto con finerenone in pazienti con CKD ... Presentation at Hot-Li-.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#52finerenone中文名,何时在中国上市,获批适应症有哪些?效果 ...
先前公布的FIDELIO-DKD研究显示,在联合标准护理时,与安慰剂相比,finerenone显著降低了CKD进展、肾衰竭、肾死亡的复合主要终点风险。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#53truc tuyen bong da youtube - Sở Y tế Hòa Bình
Kết quả của nghiên cứu giai đoạn III có tên mã FIDELIO-DKD (NCT02540993) cho thấy so với giả dược, finerenone có thể làm giảm đáng kể tỷ lệ ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#54link bong88 moi nhat 2018
Theo thông cáo báo chí do Bayer đưa ra trước đó, nghiên cứu FIDELIO-DKD là nghiên cứu quy mô lớn đầu tiên được thực hiện trên bệnh nhân CKD ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#55baccarat book Tải xuống
... trình PPT của ba công ty Hutchison Pharmaceutical, Zai Lab và Legend Bio. ... Theo thông cáo báo chí do Bayer đưa ra trước đó, nghiên cứu FIDELIO-DKD là ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#56Bayer | 蘋果健康咬一口
今日,拜耳(Bayer)公司宣布,其在研療法finerenone在治療患有2型糖尿病的慢性腎病(CKD)患者的3期臨床試驗FIDELIO-DKD中達到試驗的主要終點。
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#57Hansestadt Rostock - Kongress für NepHROlogie 2021
Diabetes: Ergebnisse der Studien FIDELIO-DKD und FIGARO-DKD ... Präsentationsmedium sind ausschließlich MS Powerpoint (*.pptx oder *.ppt).
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#58RESTRICTED - AnnualReports.com
from the presentation at the event was published in The New England Journal ... In July, we announced that our Phase III FIDELIO-DKD study ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#592021年ADA糖尿病管理指南3点更新 - 科研星球
此外,在心血管和血压单元,更新了新一代盐皮质激素受体拮抗剂finerenone 在减少糖尿病肾病的肾衰竭和疾病进展( FIDELIO-DKD ) 的研究,结果显示在 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#60Finerenone significantly reduced renal and cardiovascular ...
The findings from the FIDELIO-DKD study, which is part of the largest Phase III clinical trial program to date in CKD and T2D, were presented at ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#61郝传明-复旦大学附属华山医院 - 会务通医学学术会议平台
Presentation of Pioneer Award to Prof. ... 糖尿病合并肾病治疗新进展-FIDELIO-DKD研究结果解读. 膜性肾病60年. T2D合并CKD治疗新进展——FIDELIO-DKD研究结果解读.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#62Content Type Archives - Page 2 of 4 - Medical Conferences
Gerasimos Filippatos, Attikon University Hospital, Greece; Trial: Phase 3, FIDELIO-DKD ... Downloadable 1-Page Editor-Selected Trial PowerPoint Slides.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#63The Filter, The Pump and The Filter | PDF | Myocardial Infarction
Presentation on SGLT2 inhibitors by Dr O Bheekharry. ... FIDELIO-DKD : Finerenone in reducing KF and progression in DKD. DAPA-CKD TAKE HOME MESSAGE.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6445. Nephrologisches Seminar Heidelberg
Poster presentation at ASN Kidney Week 2016; Chicago, IL. Abstract SA-PO961. ... FIDELIO-DKD: Finerenone had consistent effects on the.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#65DR/Hussein Sheashaa - Mansourah - School and college ...
... Antagonists for The Management of Diabetic Kidney Disease: Lessons from FIDELIO-DKD Trial0:00 Introduction1:00 ... رابط المحاضرة على موقع الجمعية (ppt):
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#66resume-book-2014-scl.pdf
MS Office (Word, Excel, power point). Zd/&/ d ^. Cerificate by Yay Consuling Company ... Supported purchasing department for two weeks with Fidelio program.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#67CardioNefro-Magazine-Anno-2-Numero-1.pdf - Fenicia Eventi
Samir Morcos Rafla, in “www.slideshare. net”, (2013). ... (FIDELIO-DKD (NCT02540993) e FIGA-. RO-DKD (NCT02545049)), che si prefig-.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#68KERENDIA (finerenone) to Treat CKD Associated with Type 2 ...
In the FIDELIO-DKD trial, 5,674 patients were randomly assigned to receive either KERENDIA (N=2,833) or placebo (N=2,841).
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#69無題
Under this section, you can get immediate access to some of the free PPT ... The FIDELIO-DKD trial showed that finerenone has salutary effects on CV and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#70bong da truc tuyen .us
Bayer giới thiệu rằng NDA và đánh giá ưu tiên dựa trên dữ liệu từ thử nghiệm lâm sàng giai đoạn 3 FIDELIO-DKD. Nghiên cứu bao gồm 5734 bệnh nhân CKD và T2D ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#71bạn có biết xổ số
Nghiên cứu FIDELIO-DKD cho thấy kết quả tích cực về thận và tim mạch ... Theo PPT, việc hợp tác với Amgen đã xác minh khả năng phát triển và ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#72Bayer's finerenone meets primary endpoint in Phase III ...
Bayer's finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#73無題
Michaela hrabetova, Philips m1btbl/00 fidelio bluetooth, Peugeot 308 turbo 0-100, ... Wild bill for america islam, Eye donation procedure ppt presentations, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?>
fidelio-dkd 在 コバにゃんチャンネル Youtube 的最讚貼文
fidelio-dkd 在 大象中醫 Youtube 的最佳貼文
fidelio-dkd 在 大象中醫 Youtube 的最讚貼文